When the drug keeping her breast cancer at bay was taken off the Pharmaceutical Benefits Scheme in July, Katie-Marie Thorpe made the heart-breaking decision to remove her ovaries.
For the 34-year-old, that choice meant invasive surgery, weeks of recovery, and permanently entering surgical menopause.